Etid klinik pou Kansè kol nan Oklahoma
11 etid pou Kansè kol ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07216703A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Oklahoma Health Sciences Center, Oklahoma City
- University of Oklahoma, Oklahoma City
Ap rekriteVolontè an sante akeyi
Laj 25 ak plis · Fanm · Mizajou Jul 31, 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Stephenson Cancer Center, Oklahoma City
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Jul 30, 2026 · NCT04831580A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT06319963A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Stephenson Cancer Center, Oklahoma City
Ap rekriteFaz 2
Laj 18 a 99 · Fanm · Mizajou Oct 22, 2025 · NCT05512208A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.